Patients with acute myocardial infarction (MI - heart attack) who are referred for percutaneous coronary intervention (such as angioplasty and stent placement in the coronary artery) do not have a reduction in the amount of damaged heart tissue when administered two drugs compared with a single drug to restore blood flow, according to a study in the February 25 issue of The Journal of the American Medical Association (JAMA)
According to background information in the article, "In hospitals with catheterization facilities, primary percutaneous coronary interventions (PCIs) are better then thrombolysis (drug therapy used to dissolve blood clots) in patients with ST-segment elevation acute MI. Specifically designed randomized trials have also shown that patients with acute MI presenting at hospitals without catheterization facilities benefit more from PCI performed after transfer to centers with catheterization laboratories than from on-site thombolysis."
Adnan Kastrati, M.D., from Deutsches Hezzentrum, Technische Universitat, Munich, Germany, and colleagues from the Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators, assessed whether early administration of the combination of the drugs reteplase plus abciximab produces better reduction of infarct size compared with abciximab alone in patients with acute MI referred for PCI. The study, conducted from May 3, 2001 through June 2, 2003, included 253 patients who were admitted to 13 community hospitals without catheterization facilities (n=186) and to 5 hospitals with catheterization facilities (n=67), within 12 hours of symptoms of an acute MI. Patients randomly received either the combination of reteplase and abciximab (n=125) or abciximab (n=128) alone. All patients were then transferred for PCI. Infarct size was later determined by imaging from a single-photon emission computed tomography (SPECT).
"The final infarct size of the left ventricle, the primary enPage: 1 2 Related medicine news :1
Contact: Adnan Kastrati, M.D.
JAMA and Archives Journals
. Combination treatment helps thyroid cancer patients live longer2
. Combination therapy, not medication alone, most effective for treating children with OCD3
. Combination of erection pill and testosterone gel may benefit men who fail treatment with pill alone4
. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia5
. Combination PET/CT should be used to determine stage of non-small cell lung cancer6
. Combination of toxin and poison may be novel treatment for leukemia7
. Combination drug therapy could substantially improve symptoms of rheumatoid arthritis8
. Combination drug therapy offers hope for malaria treatment9
. Combination therapy significantly delays progression of benign prostatic hyperplasia10
. Combination, order of anti-HIV drugs make a difference in first-time recipients11
. Combination of HIV/malaria increases complications during pregnancy